Intensifying induction therapy in acute myeloid leukemia: has a new standard of care emerged?

Shorter long-term post-transplant life expectancy may be due to prior chemotherapy for the underlying disease: analysis of 3012 patients with acute myeloid leukemia enrolled on 9 consecutive ECOG-ACRIN trials.

Bone marrow transplantation·2024

Acute myeloid leukemia with 11q23 rearrangements: A study of therapy-related disease and therapeutic outcomes.

Leukemia research·2020

The evolving role of chemotherapy and hematopoietic cell transplants in Ph-positive acute lymphoblastic leukemia in adults.

Bone marrow transplantation·2017

Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide.

Leukemia·2017

The NIST Cold Neutron Research Facility.

Journal of research of the National Institute of Standards and Technology·2017

Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia.

Blood cancer journal·2016

Multi-omics reveals evolution from CD7-negative T cell dysregulation to EBV-positive LPD after CD7 CAR-T therapy.

Blood·2026

Low Incidence of Cryptic Genetic Marrow Failure in Pediatric Severe Aplastic Anemia Following Negative Clinical Workup.

Blood·2026

Initial fixed low-versus moderate-dose hydroxyurea assignment in the long-term follow-up of the SPRINT cohort.

Blood·2026

Molecular Underpinnings and Prevalence of Donor Cell-Derived Hematologic Neoplasms among Spanish Transplantation Centers.

Blood·2026

Splicing Factor Mutations in Myeloid Malignancies.

Blood·2026

CD8 T-cell exhaustion linked with CAR T-cell failure can be mitigated by a non-alpha IL2 receptor agonist.

Blood·2026

BTK Inhibitor Ibrutinib Reduces Bispecific Antibody-Related CRS Without Undermining the Anti-Tumor Efficacy.

Cancer science·2026

Ikaros degradation by Iberdomide correlates with normalization of cytokines in Th cells of patients with systemic lupus erythematosus.

Journal of immunology (Baltimore, Md. : 1950)·2026

The Place of Therapeutic Apheresis in Severe Immune-Related Adverse Events: A Scoping Review of Literature.

Journal of clinical apheresis·2026

[Nontuberculous mycobacterial infections in patients with hematologic diseases].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[The role of MAGIC biomarkers in acute GVHD].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Current treatment strategies for diffuse large B-cell lymphoma].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

Intensifying induction therapy in acute myeloid leukemia: has a new standard of care emerged?

Related Experiment Videos

Related Concept Videos

Shorter long-term post-transplant life expectancy may be due to prior chemotherapy for the underlying disease: analysis of 3012 patients with acute myeloid leukemia enrolled on 9 consecutive ECOG-ACRIN trials.

Acute myeloid leukemia with 11q23 rearrangements: A study of therapy-related disease and therapeutic outcomes.

The evolving role of chemotherapy and hematopoietic cell transplants in Ph-positive acute lymphoblastic leukemia in adults.

Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide.

The NIST Cold Neutron Research Facility.

Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia.

Multi-omics reveals evolution from CD7-negative T cell dysregulation to EBV-positive LPD after CD7 CAR-T therapy.

Low Incidence of Cryptic Genetic Marrow Failure in Pediatric Severe Aplastic Anemia Following Negative Clinical Workup.

Initial fixed low-versus moderate-dose hydroxyurea assignment in the long-term follow-up of the SPRINT cohort.

Molecular Underpinnings and Prevalence of Donor Cell-Derived Hematologic Neoplasms among Spanish Transplantation Centers.

Splicing Factor Mutations in Myeloid Malignancies.

CD8 T-cell exhaustion linked with CAR T-cell failure can be mitigated by a non-alpha IL2 receptor agonist.

BTK Inhibitor Ibrutinib Reduces Bispecific Antibody-Related CRS Without Undermining the Anti-Tumor Efficacy.

Ikaros degradation by Iberdomide correlates with normalization of cytokines in Th cells of patients with systemic lupus erythematosus.

The Place of Therapeutic Apheresis in Severe Immune-Related Adverse Events: A Scoping Review of Literature.

[Nontuberculous mycobacterial infections in patients with hematologic diseases].

[The role of MAGIC biomarkers in acute GVHD].

[Current treatment strategies for diffuse large B-cell lymphoma].

Intensifying induction therapy in acute myeloid leukemia: has a new standard of care emerged?

Related Experiment Videos

Related Concept Videos

Related Articles